5.58
+0.04
(0.72%)
May 17 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 5.50 - 5.63 |
| 52 week | 2.96 - 6.32 |
| Open | 5.52 |
| Vol / Avg. | 27,474.00/126,672.00 |
| Mkt cap | 204.17M |
| P/E | - |
| Div/yield | - |
| EPS | -0.38 |
| Shares | 36.59M |
| Beta | 1.92 |
| Inst. own | - |
Events
Aug 5, 2013
Q2 2013 Compugen Earnings Release
Apr 29, 2013
Q1 2013 Compugen Earnings Release
Apr 25, 2013
Q1 2013 Compugen Ltd Earnings Conference Call -
Apr 15, 2013
Compugen Annual Shareholder Meeting
Mar 11, 2013
Compugen at EBD BIO-Europe Spring
Feb 20, 2013
Q4 And Full Year 2012 Compugen Earnings Conference Call -
Feb 20, 2013
Q4 And Full Year 2012 Compugen Earnings Release
|
More events from DailyFinance »
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -4009.70% | -5631.40% |
| Operating margin | -2866.42% | -5595.87% |
| EBITD margin | - | -5472.31% |
| Return on average assets | -75.65% | -47.00% |
| Return on average equity | -118.53% | -73.16% |
| Employees | 52 | - |
| Carbon Disclosure Rating | - | - |
Address
72 Pinchas Rosen St.
TEL AVIV-YAFO, 69512
Israel
+972-3-7658585 (Phone)
+972-3-7658555 (Fax)
TEL AVIV-YAFO, 69512
Israel
+972-3-7658585 (Phone)
+972-3-7658555 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Compugen develops accelerator products for algorithms used to analyze DNA generated by means of high throughput sequencing. The Company develops bioinformatics hardware and software based on proprietary algorithms.
Officers and directors
| Martin S. Gerstl | Chairman of the Board | |
| Anat Cohen-Dayag Ph.D. | President, Chief Executive Officer | |
| Dikla Czaczkes | Chief Financial Officer & Investor Relations Contact | |
| Zurit Levine Ph.D. | Vice President - Research and Discovery | |
| Eyal Neria | Vice President of Therapeutic Development | |
| Dov Hershberg | Director | |
| Alex Kotzer | Director | |
| Yair Aharonowitz Ph.D. | Independent External Director | |
| Ruth Arnon | Independent Director | |
| Arie Ovadia | Independent External Director |